Vice President, Drug Safety and Pharmacovigilance (DSPV)
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases.The Role:
The Vice President of Drug Safety and Pharmacovigilance (VP, DSPV) will serve as the global leader for Immunovant product safety and report to the Chief Operating Officer. The individual will provide strategic vision and operational oversight across all aspects of drug safety while ensuring regulatory compliance globally.
The VP, DSPV will lead all pre- and post-marketing safety, PV and risk management activities. The incumbent in this position must effectively interface cross-functionally at all levels in the organization as well as with external regulatory authorities. The VP, DSPV oversees and is responsible for the integration of pre-and post-marketing safety surveillance with Clinical Development and Medical Affairs activities and for ensuring an integrated and proactive approach to risk management. The VP, DSPV is also responsible for managing the organizational planning, budget and operations of the department.
Key Responsibilities:
Authority and accountability to develop, organize, manage and maintain a highly compliant PV system for Immunovant
Medical expert accountable for overall DSPV strategy and all deliverables of the DSPV function, including responsibilities for pharmacovigilance-related documents (e.g., DSUR) as well as safety sections of key documents (e.g., IBs, RSI, ICFs, study protocols, CSRs) and other applicable activities (IND/CTA, requests for information, regulatory responses)
Strategic decision maker accountable for providing medical and scientific expertise for product safety and risk assessments at all stages of product lifecycle
Responsible for oversight of the DSPV department, including building and managing a team of DSPV professionals (operations and safety science) to execute the development strategy and support registrational/post-marketing activities in a compliant and collaborative environment, in accordance with long-term strategic goals
Serves as lead safety representative in regulatory interactions and interactions with internal governance frameworks
Provide medical and drug safety expertise to enable decision-making based on ongoing risk-benefit assessment and clinical trial data interpretation
Collaborate with appropriate (clinical, medical, quality, and regulatory counterparts and others across the business), to provide input and oversight for all safety and PV issues
Responsible for leading relevant Safety committees and teams
Oversee drug safety and pharmacovigilance activities conducted in partnership with external business partners or outsourced to vendors and contract research organizations
Ensure ongoing audit and inspection readiness of the DSPV function.
Responsible for department planning and forecasting efforts in relation to resources and overall management of PV budget.
Requirements:
MD or equivalent degree; additional training/experience with rare diseases is preferred
12 + years of relevant industry experience in biotech and/or pharmaceutical settings with significant time spent in senior leadership roles, including 5+ years of direct experience in Drug Safety and Pharmacovigilance (development and commercial stage)
Oversight experience of global medical safety activities, operations, and risk management strategies in pre and post marketing environments
Extensive knowledge of regulatory and compliance requirements governing drug safety and pharmacovigilance, as well as an overall understanding and knowledge of BLA global filing requirements
Proven prior experience with guiding a Drug Safety and Pharmacovigilance team through BLA and commercialization
Experience in building out DSPV marketed product infrastructure
Demonstrated thorough knowledge of relevant FDA, EU, ICH guidelines, initiatives and regulations governing both Safety reporting and processing for clinical trial environments
Excellent clinical judgment and ability to communicate complex clinical issues in a scientifically sound and understandable way
Ability to combine pharmacovigilance expertise with exceptional leadership (strategic thinking, people, and resource management )
Excellent organizational skills and an ability to prioritize effectively to deliver results within aggressive timelines with the ability to work independently and as part of a team
Strong interpersonal skills including verbal and written communication
Work Environment:
Remote-based
Dynamic, interactive, fast-paced, and entrepreneurial environment
Domestic or international travel is required (10-20%)
Salary range for posting$400,000—$425,000 USDCompensation is based on a number of factors, including market location, and may vary depending on job-related knowledge, skills, and experience. Equity and other forms of compensation may be provided as part of a total compensation package, in addition to a full range of medical, dental, vision, 401k, and other benefits, including unlimited paid time off and parental leave.
Apply Now
The Vice President of Drug Safety and Pharmacovigilance (VP, DSPV) will serve as the global leader for Immunovant product safety and report to the Chief Operating Officer. The individual will provide strategic vision and operational oversight across all aspects of drug safety while ensuring regulatory compliance globally.
The VP, DSPV will lead all pre- and post-marketing safety, PV and risk management activities. The incumbent in this position must effectively interface cross-functionally at all levels in the organization as well as with external regulatory authorities. The VP, DSPV oversees and is responsible for the integration of pre-and post-marketing safety surveillance with Clinical Development and Medical Affairs activities and for ensuring an integrated and proactive approach to risk management. The VP, DSPV is also responsible for managing the organizational planning, budget and operations of the department.
Key Responsibilities:
Authority and accountability to develop, organize, manage and maintain a highly compliant PV system for Immunovant
Medical expert accountable for overall DSPV strategy and all deliverables of the DSPV function, including responsibilities for pharmacovigilance-related documents (e.g., DSUR) as well as safety sections of key documents (e.g., IBs, RSI, ICFs, study protocols, CSRs) and other applicable activities (IND/CTA, requests for information, regulatory responses)
Strategic decision maker accountable for providing medical and scientific expertise for product safety and risk assessments at all stages of product lifecycle
Responsible for oversight of the DSPV department, including building and managing a team of DSPV professionals (operations and safety science) to execute the development strategy and support registrational/post-marketing activities in a compliant and collaborative environment, in accordance with long-term strategic goals
Serves as lead safety representative in regulatory interactions and interactions with internal governance frameworks
Provide medical and drug safety expertise to enable decision-making based on ongoing risk-benefit assessment and clinical trial data interpretation
Collaborate with appropriate (clinical, medical, quality, and regulatory counterparts and others across the business), to provide input and oversight for all safety and PV issues
Responsible for leading relevant Safety committees and teams
Oversee drug safety and pharmacovigilance activities conducted in partnership with external business partners or outsourced to vendors and contract research organizations
Ensure ongoing audit and inspection readiness of the DSPV function.
Responsible for department planning and forecasting efforts in relation to resources and overall management of PV budget.
Requirements:
MD or equivalent degree; additional training/experience with rare diseases is preferred
12 + years of relevant industry experience in biotech and/or pharmaceutical settings with significant time spent in senior leadership roles, including 5+ years of direct experience in Drug Safety and Pharmacovigilance (development and commercial stage)
Oversight experience of global medical safety activities, operations, and risk management strategies in pre and post marketing environments
Extensive knowledge of regulatory and compliance requirements governing drug safety and pharmacovigilance, as well as an overall understanding and knowledge of BLA global filing requirements
Proven prior experience with guiding a Drug Safety and Pharmacovigilance team through BLA and commercialization
Experience in building out DSPV marketed product infrastructure
Demonstrated thorough knowledge of relevant FDA, EU, ICH guidelines, initiatives and regulations governing both Safety reporting and processing for clinical trial environments
Excellent clinical judgment and ability to communicate complex clinical issues in a scientifically sound and understandable way
Ability to combine pharmacovigilance expertise with exceptional leadership (strategic thinking, people, and resource management )
Excellent organizational skills and an ability to prioritize effectively to deliver results within aggressive timelines with the ability to work independently and as part of a team
Strong interpersonal skills including verbal and written communication
Work Environment:
Remote-based
Dynamic, interactive, fast-paced, and entrepreneurial environment
Domestic or international travel is required (10-20%)
Salary range for posting$400,000—$425,000 USDCompensation is based on a number of factors, including market location, and may vary depending on job-related knowledge, skills, and experience. Equity and other forms of compensation may be provided as part of a total compensation package, in addition to a full range of medical, dental, vision, 401k, and other benefits, including unlimited paid time off and parental leave.
Apply Now